×

Sen. Grassley: Need more transparency in drug pricing

2:37 PM ET Thu, 25 Aug 2016

Sen. Charles Grassley (R-Iowa), reacts to what Mylan CEO Heather Bresch had to say about the EpiPen pricing outrage.